haloperidol and opipramol

haloperidol has been researched along with opipramol in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fiechtner, B; Glossmann, H; Hoffmann, RD; Laggner, C; Langer, T; Moebius, FF; Poles, G; Schieferer, C1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Cler, JA; Contreras, PC; Dilworth, VM; Iyengar, S; Mick, SJ; Rao, TS; Wood, PL1
Barcikowska, M; Blair, IP; Brooks, WS; Coupland, KG; Dobson-Stone, C; Halliday, GM; Karlström, H; Kwok, JB; Loy, CT; Luty, AA; Maruszak, A; Mather, KA; Panegyres, PK; Sachdev, PS; Schofield, PR; Sobow, T; Tchorzewska, J; Williams, KL; Zekanowski, C1

Other Studies

4 other study(ies) available for haloperidol and opipramol

ArticleYear
Discovery of high-affinity ligands of sigma1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening.
    Journal of medicinal chemistry, 2005, Jul-28, Volume: 48, Issue:15

    Topics: Animals; Carrier Proteins; Databases, Factual; Guinea Pigs; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Isomerism; Ligands; Models, Molecular; Quantitative Structure-Activity Relationship; Radioligand Assay; Receptors, sigma; Saccharomyces cerevisiae; Sigma-1 Receptor; Steroid Isomerases

2005
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Neurochemical characterization of dopaminergic effects of opipramol, a potent sigma receptor ligand, in vivo.
    Neuropharmacology, 1990, Volume: 29, Issue:12

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Corpus Striatum; Dopamine; Haloperidol; Homovanillic Acid; Ligands; Male; Mice; Opipramol; Organ Specificity; Phencyclidine; Piperidines; Quinolines; Rats; Rats, Inbred Strains; Receptors, Neurotransmitter; Receptors, Opioid; Receptors, Phencyclidine; Receptors, sigma

1990
Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease.
    Annals of neurology, 2010, Volume: 68, Issue:5

    Topics: Aged; Aged, 80 and over; Brain; Cell Line, Transformed; DNA-Binding Proteins; Female; Frontotemporal Lobar Degeneration; Haloperidol; Humans; Lymphocytes; Male; Middle Aged; Motor Neuron Disease; Mutation; Opipramol; Pedigree; Phenylacetates; Pyrrolidines; Receptors, sigma; RNA-Binding Protein FUS; Sigma-1 Receptor

2010